Heart Attack

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market

Global anti-hypertensive drug market projected to reach $37.24 billion by 2034Enalapril is a widely prescribed ACE inhibitor used to treat...

New Pharmacoeconomic Analysis Finds KYZATREX® Could Cut the VA’s Total Cost of Testosterone Care by Nearly Half for America’s Veterans

Model projects up to $16.2 million in potential annual savings for every 50,000 veterans transitioned from office-administered injectable therapy —...

Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer

Appointments to scale adoption of Caristo's AI-powered cardiovascular technologies globallyOXFORD, England and STAMFORD, Conn., July 23, 2026 /PRNewswire/ -- Caristo...

Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved

First GLP-1 pill approved in the European Union for the treatment of obesity and overweightOnly Wegovy® pill demonstrates 17%* mean...

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on...

Oncologists Say Cancer Care Starts Too Late – PreOncology™ Launches New Medical Specialty Focused on Finding Cancer Before Stage I

New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...

Oncologists Say Cancer Care Starts Too Late – PreOncology™ Launches New Medical Specialty Focused on Finding Cancer Before Stage I

New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time...

Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress

Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled trial...

error: Content is protected !!